Silvercrest Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,560
Closed -$147K 596
2017
Q3
$147K Hold
11,560
﹤0.01% 542
2017
Q2
$137K Hold
11,560
﹤0.01% 526
2017
Q1
$171K Hold
11,560
﹤0.01% 558
2016
Q4
$187K Sell
11,560
-1,000
-8% -$18.1K ﹤0.01% 560
2016
Q3
$228K Sell
12,560
-3,000
-19% -$58.6K ﹤0.01% 501
2016
Q2
$256K Sell
15,560
-1,000
-6% -$16.2K ﹤0.01% 492
2016
Q1
$274K Hold
16,560
﹤0.01% 477
2015
Q4
$359K Hold
16,560
0.01% 461
2015
Q3
$328K Sell
16,560
-2,000
-11% -$63.2K 0.01% 410
2015
Q2
$645K Hold
18,560
0.01% 376
2015
Q1
$482K Sell
18,560
-7,600
-29% -$139K 0.01% 378
2014
Q4
$337K Buy
+26,160
New +$327K ﹤0.01% 393

Other funds holding HZNP